A cancer charity has said it is "angry and frustrated" that ministers and health officials have not approved the provision of ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

The retired NBA pro, who was diagnosed with kidney cancer at age 41, wants to give hope to others undergoing health challenges.

Men who experience acute adverse effects after radiation therapy for prostate cancer may be at higher risk for more serious ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

A football fan from Dorchester is taking the fight to prostate cancer by walking more than 2 million steps in six months ...

Prostate cancer was the second leading cause of cancer deaths in North Carolina men in 2021; the bill aims to lower those rates.

Massey Comprehensive Cancer Center in Richmond is the first site in Virginia to offer a new non-surgical robotic ultrasound ...